WuXi AppTec has opened its new 150,000-sq.-ft. biomanufacturing facility in Philadelphia, PA that could eventually employ an additional 200 manufacturing and support staff. This facility is designed for cell therapy products that use viral vectors, such as chimeric antigen receptor T cell (CAR T cell) therapies, and will allow expansion of viral vector manufacturing to support gene therapy clinical and commercial programs and large scale production in 2,000L single-use bioreactors. The new...